Published ahead of print on May 13, 2003, doi:10.1164/rccm.200210-1164OC
American Journal of Respiratory and Critical Care Medicine Vol 168. pp. 476-480, (2003)
© 2003 American Thoracic Society
Pneumococcal Septic Shock Is Associated with the Interleukin-101082 Gene Promoter Polymorphism
Bernhard M. Schaaf,
Florian Boehmke,
Hamed Esnaashari,
Ulrike Seitzer,
Henning Kothe,
Matthias Maass,
Peter Zabel and
Klaus Dalhoff
Department of Medicine III and Institute of Medical Microbiology and Hygiene, University of Schleswig Holstein, Campus Lübeck, Lübeck; and Medical Clinic and Department of Immunology and Cell Biology, Research Center Borstel, Borstel, Germany
Correspondence and requests for reprints should be addressed to Klaus Dalhoff, M.D., Medizinische Klinik III, Medizinische Universität zu Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany. E-mail: klaus.dalhoff{at}medinf.mu-luebeck.de
Polymorphisms in the tumor necrosis factor and interleukin-10 genes, linked to cytokine inducibility, may influence the inflammatory response to infection. We studied the biallelic interleukin-101082 promoter, the tumor necrosis factor- -308 promoter, and the lymphotoxin- polymorphisms with regard to the development of septic shock in pneumococcal infection. Sixty-nine patients with pneumococcal disease (61 patients with community-acquired pneumonia, 5 patients with meningitis, and 3 patients with pneumonia and meningitis) and 50 age-matched control subjects were included. The polymorphisms were determined by the polymerase chain reaction. In patients with pneumococcal disease, the lipopolysaccharide-stimulated tumor necrosis factor and interleukin-10 release from whole blood were measured by ELISA. Sepsis severity was documented according to standard criteria. No significant genotypic differences were seen between patients and control subjects. Thirteen of 69 patients with pneumococcal disease developed septic shock. Interleukin-10 allele G homozygous patients had the highest risk for septic shock (odds ratio of 6.1; 95% confidence interval, 1.427.2; corrected p = 0.024). The stimulated interleukin-10 release was highest in interleukin-10 G homozygous patients (p = 0.04). In conclusion, interleukin-10 polymorphism, associated with high interleukin-10 inducibility, might influence the outcome of pneumococcal infection via induced immunosuppression and impaired bacterial clearance.
Key Words: tumor necrosis factor- polymorphism lymphotoxin- polymorphism genetic predisposition
This article has been cited by other articles:

|
 |

|
 |
 
R Menendez, R Martinez, S Reyes, J Mensa, X Filella, M A Marcos, A Martinez, C Esquinas, P Ramirez, and A Torres
Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia
Thorax,
July 1, 2009;
64(7):
587 - 591.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. C. Deans, B. H. Tan, J. A Ross, M. Rose-Zerilli, S. J Wigmore, W M. Howell, R. F Grimble, and K. C. Fearon
Cancer cachexia is associated with the IL10 -1082 gene promoter polymorphism in patients with gastroesophageal malignancy
Am. J. Clinical Nutrition,
April 1, 2009;
89(4):
1164 - 1172.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Flores, H. L. DuPont, S. A. Lee, J. Belkind-Gerson, M. Paredes, J. A. Mohamed, L. Y. Armitige, D.-C. Guo, and P. C. Okhuysen
Influence of Host Interleukin-10 Polymorphisms on Development of Traveler's Diarrhea Due to Heat-Labile Enterotoxin-Producing Escherichia coli in Travelers from the United States Who Are Visiting Mexico
Clin. Vaccine Immunol.,
August 1, 2008;
15(8):
1194 - 1198.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Hjuler, G. Poulsen, J. Wohlfahrt, M. Kaltoft, R. J. Biggar, and M. Melbye
Genetic Susceptibility to Severe Infection in Families with Invasive Pneumococcal Disease
Am. J. Epidemiol.,
April 1, 2008;
167(7):
814 - 819.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Menendez and A. Torres
Treatment Failure in Community-Acquired Pneumonia
Chest,
October 1, 2007;
132(4):
1348 - 1355.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. V. Giannoudis, M. van Griensven, E. Tsiridis, and H. C. Pape
The genetic predisposition to adverse outcome after trauma
J Bone Joint Surg Br,
October 1, 2007;
89-B(10):
1273 - 1279.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Schaaf, J. Kruse, J. Rupp, R. R. Reinert, D. Droemann, P. Zabel, S. Ewig, and K. Dalhoff
Sepsis severity predicts outcome in community-acquired pneumococcal pneumonia
Eur. Respir. J.,
September 1, 2007;
30(3):
517 - 524.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.-A. Krayenbuehl, F. E. Maly, M. Hersberger, P. Wiesli, A. Himmelmann, K. Eid, P. Greminger, W. Vetter, and G. Schulthess
Tumor Necrosis Factor-{alpha} -308G>A Allelic Variant Modulates Iron Accumulation in Patients with Hereditary Hemochromatosis
Clin. Chem.,
August 1, 2006;
52(8):
1552 - 1558.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. N. Gong, B. T. Thompson, P. L. Williams, W. Zhou, M. Z. Wang, L. Pothier, and D. C. Christiani
Interleukin-10 polymorphism in position -1082 and acute respiratory distress syndrome.
Eur. Respir. J.,
April 1, 2006;
27(4):
674 - 681.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Wattanathum, S. Manocha, H. Groshaus, J. A. Russell, and K. R. Walley
Interleukin-10 Haplotype Associated With Increased Mortality in Critically Ill Patients With Sepsis From Pneumonia But Not in Patients With Extrapulmonary Sepsis
Chest,
September 1, 2005;
128(3):
1690 - 1698.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Alberti, C. Brun-Buisson, S. Chevret, M. Antonelli, S. V. Goodman, C. Martin, R. Moreno, A. R. Ochagavia, M. Palazzo, K. Werdan, et al.
Systemic Inflammatory Response and Progression to Severe Sepsis in Critically Ill Infected Patients
Am. J. Respir. Crit. Care Med.,
March 1, 2005;
171(5):
461 - 468.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Sutherland, K. R. Walley, S. Manocha, and J. A. Russell
The Association of Interleukin 6 Haplotype Clades With Mortality in Critically Ill Adults
Arch Intern Med,
January 10, 2005;
165(1):
75 - 82.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. Fox, S. K. Shernan, and S. C. Body
Predictive Genomics of Adverse Events After Cardiac Surgery
Seminars in Cardiothoracic and Vascular Anesthesia,
December 1, 2004;
8(4):
297 - 315.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J.A. Preston, K.W. Beagley, P.G. Gibson, and P.M. Hansbro
Genetic background affects susceptibility in nonfatal pneumococcal bronchopneumonia
Eur. Respir. J.,
February 1, 2004;
23(2):
224 - 231.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Tobin
Critical Care Medicine in AJRCCM 2003
Am. J. Respir. Crit. Care Med.,
January 15, 2004;
169(2):
239 - 253.
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 American Thoracic Society
|
|
|